Home/Annexon/Beth Seidenberg, M.D.
BS

Beth Seidenberg, M.D.

Board Member

Annexon

Roles

Board MemberatAnnexon

Annexon Pipeline

DrugIndicationPhase
ANX005Guillain-Barré Syndrome (GBS)Phase 2/3
ANX007Geographic Atrophy (GA) secondary to AMDPhase 2
ANX009Complement-mediated diseasesPreclinical